Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31244335)

  • 1. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
    Jiang Q; Sun Y; Liu X
    Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta-analysis.
    Wang Y; Gao F; Zhao M; Li B; Xing D; Wang J; Yang Y
    J Cell Mol Med; 2016 May; 20(5):836-41. PubMed ID: 26859127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer.
    Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
    Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
    Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
    Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.
    Wu J; Wu X; Liang W; Chen C; Zheng L; An H
    Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.
    He H; Wang C; Shen Z; Fang Y; Wang X; Chen W; Liu F; Qin X; Sun Y
    PLoS One; 2013; 8(8):e71864. PubMed ID: 23936528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
    Zhang C; Li J; Han Y; Jiang J
    Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
    Du Y; Long Q; Guan B; Mu L
    Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer.
    Li Y; Wang HC; Wang JS; Sun B; Li LP
    FEBS Open Bio; 2020 Jun; 10(6):1149-1161. PubMed ID: 32306562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
    Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
    Qiu L; Xu Y; Xu H; Yu B
    BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
    Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.
    Weixler B; Renetseder F; Facile I; Tosti N; Cremonesi E; Tampakis A; Delko T; Eppenberger-Castori S; Tzankov A; Iezzi G; Kettelhack C; Soysal SD; von Holzen U; Spagnoli GC; Terracciano L; Tornillo L; Droeser RA; Däster S
    Cell Oncol (Dordr); 2017 Dec; 40(6):609-619. PubMed ID: 28936810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.